Beam Base Editor’s Early Data in Rare Liver Disease Tee Up $500M Stock Sale in Tough Market
A Beam Therapeutics gene-editing therapy designed to fix a mutation at the root of a rare liver protein deficiency now ...
A Beam Therapeutics gene-editing therapy designed to fix a mutation at the root of a rare liver protein deficiency now ...
Credit: Pixabay/CC0 Public Domain Incidents of children in the US being poisoned by the synthetic opioid fentanyl "increased and became ...
A study yesterday in JAMA suggests Paxlovid, the oral antiviral approved for use against severe COVID-19 symptoms, did little to ...
Top advisers to the Centers for Disease Control and Prevention are asking the agency’s acting director to explain the abrupt ...
Health data is a prime target of hackers given the value of healthcare data – in fact it is considered ...
A randomized clinical trial conducted in seven countries has identified three new options for shorter, all-oral treatment of drug-resistant tuberculosis ...
The Administration for Strategic Preparedness and Response (ASPR) announced yesterday that it will give drugmaker Shionogi, Inc, $375 million to ...
The World Health Organization has implored China to share data and access to help understand the origins of Covid-19, five ...
The cyberattack that Ascension suffered in May resulted in the exposure of 5.6 million patients’ personal and health information, according ...
Good morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and invigorating, because the ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.